BWM
ALNY icon

Baystate Wealth Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Baystate Wealth Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$101K Hold
527
– – 0.01% 273
2023
Q3 		$93.3K Hold
527
– – 0.01% 262
2023
Q2 		$100K Hold
527
– – 0.01% 256
2023
Q1 		$106K Hold
527
– – 0.01% 244
2022
Q4 		$125K Hold
527
– – 0.01% 231
2022
Q3 		$105K Hold
527
– – 0.01% 228
2022
Q2 		$77K Hold
527
– – 0.01% 266
2022
Q1 		$86K Sell
527
-528
-50% -$80.4K 0.01% 259
2021
Q4 		$179K Hold
1,055
– – 0.02% 188
2021
Q3 		$199K Hold
1,055
– – 0.02% 151
2021
Q2 		$179K Hold
1,055
– – 0.02% 153
2021
Q1 		$149K Buy
+1,055
New +$159K 0.02% 154
2017
Q1 		– Sell
-460
Closed -$19K – 661
2016
Q4 		$19K Buy
+460
New +$19.3K ﹤0.01% 234

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return